Australian University Rankings Guide

Oncology Reports: an international journal devoted to fundamental and applied research in oncology (ERA Journal)

Oncology Reports: an international journal devoted to fundamental and applied research in oncology is an ERA accredited research journal used as part of the evaluation of the ERA research rankings.

Oncology Reports: an international journal devoted to fundamental and applied research in oncology issns are issn1: 1021-335X issn2: 1791-2431.

The field covered by Oncology Reports: an international journal devoted to fundamental and applied research in oncology as part of the evaluation of Australian university research excellence is:

Oncology and Carcinogenesis Research Rankings (Sub-Field)

Other ERA-accredited journals supporting the evaluation of the Oncology and Carcinogenesis field include:

- Annals of Oncology
- Asia Pacific Journal of Clinical Oncology
- Bone Marrow Transplantation
- Breast Cancer Research
- Cancer Control: journal of the Moffitt Cancer Center
- Cancer and Clinical Oncology
- Clinical and Translational Science
- Current Opinion in Oncology
- European Journal of Oncology Nursing (EJON)
- Gynecologic Oncology
- Indian Journal of Medical and Paediatric Oncology
- Journal of Clinical Oncology in Adolescents and Young Adults
- Journal of Experimental and Clinical Cancer Research
- Journal of Thoracic Oncology
- Medical Oncology


ERA Research Rankings Submenu


- ERA 2018 Outcomes Research Rankings List

- ERA 2018 Research Rankings Analysis

- ERA 2018 Individual University Outcomes List

- ERA List of Research Fields Rankings

- ERA Journal Rankings 2018 List



Latest News and Updates:


- Top 10 Best Australian Universities

- Gender Balance Male-Female Ratio

- ERA 2018 Outcomes Research Rankings List

- University Bachelor Degree Completion Rates

- QS Employability Rankings Australian Universities

- ARWU World Rankings of Australian Universities

- Group of Eight (go8) World Rankings

Share This Page

  • Share on Facebook1
  • Share on Twitter2
  • Share on Linkedin3
  • Share on Reddit4